主动脉瓣置换设备市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00002871
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 165
Buy Now

【研究报告】2022年主动脉瓣置换装置市场规模为711,339万美元,预计到2030年将达到1807,032万美元。预计2022-2030年复合年增长率为12.4%。

分析师观点

主动脉瓣置换装置市场分析解释了主动脉瓣置换手术数量不断增加和对微创技术的需求不断增加等驱动因素。此外,临床研究数量的增加是 2022-2030 年市场增长的未来趋势。按产品划分,2022 年无缝瓣膜细分市场将在主动脉瓣置换装置市场中占据较大份额。在手术方面,微创手术细分市场将在 2022 年占据主导地位。按最终用户划分,医院和诊所细分市场将占据主导地位。在预测期内以相当大的份额主导主动脉瓣置换设备市场。

主动脉瓣是调节流经心脏的血流的四种瓣膜之一。主动脉瓣将心脏的主泵室和向身体供应富氧血液的主动脉分开。主动脉瓣修复或主动脉瓣置换术可治疗主动脉瓣疾病,帮助恢复正常血流,减轻症状,延长生命,并有助于保护心肌功能。

战略见解
市场洞察

主动脉瓣置换手术数量的增加促进了主动脉瓣置换设备市场的增长

全球范围内进行的主动脉瓣置换手术数量显着增加最近。根据德克萨斯赫拉特研究所发布的数据,美国每年进行约 106,000 例心脏瓣膜手术。几乎所有这些手术都会修复或更换二尖瓣或主动脉瓣。这种激增可归因于多种因素,包括医疗技术的进步、人口老龄化以及对心脏相关疾病的认识提高。主动脉瓣置换术是一项关键手术,通常用于治疗主动脉瓣狭窄或反流,如果不及时治疗,可能会导致严重的并发症。随着医学科学的不断发展,这些手术预计将变得更加安全和容易,有助于改善患者的治疗效果并提高受主动脉瓣疾病影响的患者的生活质量。医疗保健系统正在适应这种不断增长的手术干预需求,强调预防措施和早期检测在管理心血管健康方面的重要性。

技术进步正在主动脉瓣置换设备市场创造利润丰厚的机会
>
微创手术技术 (MIS) 的发展,例如经导管主动脉瓣置换术 (TAVR),使主动脉瓣狭窄 (AS) 的治疗现代化。经导管,例如经导管主动脉瓣置换术(TAVR),使主动脉瓣狭窄(AS)的治疗现代化。经导管主动脉瓣置换术比传统的心脏直视手术侵入性更小,使得不适合手术的高危患者能够接受治疗。此外,材料和设计的发展导致了更坚固和生物相容性主动脉瓣置换术的开发,这改善了患者的治疗效果并降低了并发症的风险。

主动脉领域参与者的一些技术进步瓣膜置换装置如下:

2023 年 1 月,雅培 (Abbott) 的 Navitor 经导管主动脉瓣植入 (TAVI) 系统获得 FDA 批准,用于治疗心脏直视手术高风险的严重主动脉瓣狭窄患者。 Navitor 是该公司广泛的经导管结构性心脏产品组合的最新成员,为医生和患者提供针对一系列严重心脏病的微创治疗选择。 2022 年 9 月,美敦力宣布扩展其最新一代自扩张 TAVR 系统—Evolut FX TAVR 系统 — 美国。 Evolut FX 在现有 Evolut 平台上添加了新功能,以增强医生的易用性和可预测的瓣膜部署。 2022 年 9 月,Edwards Lifesciences 推出了 SAPIEN 3 Ultra RESILIA 瓣膜,其中包括 Edwards 突破性的 RESILIA 组织技术与行业领先的 SAPIEN 3 超经导管主动脉心脏瓣膜。此次推出是在最近获得美国食品和药物管理局 (FDA) 批准之后推出的。 2021 年 9 月,雅培 (Abbott) 的 Epic Plus 和 Epic Plus Supra 支架组织瓣膜获得 FDA 批准,以改善主动脉瓣或二尖瓣疾病患者的治疗选择。通过这款新设备,雅培扩展了其 Epic 手术瓣膜平台。 2021 年 8 月,CORCYM 在现实环境中招募了第一位患者进行二尖瓣、主动脉和三尖瓣上市后研究,即 MANTRA。意大利莱切市医院首次植入 Bicarbon 主动脉机械瓣膜。2021 年 8 月,首个印度制造 3D 打印心脏瓣膜在钦奈开发出来。新型心脏瓣膜是利用3D打印机开发的,可以克服人工心脏瓣膜的相关问题。2020年9月,波士顿科学公司在欧洲推出了ACURATE neo2主动脉瓣系统。新一代 TAVI 技术是一个具有多种功能的新平台,旨在提高原始 ACURATE neo 平台的临床表现,与上一代主动脉瓣系统相比,它扩大了主动脉瓣狭窄患者的适应症。因此,技术进步正在主动脉瓣置换装置市场创造利润丰厚的机会。

报告细分和范围

基于产品的见解

基于产品,主动脉瓣瓣膜置换装置市场分为机械瓣膜和无缝线瓣膜。无缝线瓣膜细分市场在 2022 年占据更大的市场份额,并且可能在 2022 年至 2030 年期间在主动脉瓣置换装置市场实现显着的复合年增长率。无缝线主动脉瓣置换装置是一种生物瓣膜,设计用于无需传统缝合即可将瓣膜固定到位。这些瓣膜通常由生物材料制成。该瓣膜连接到支架或框架上,一旦将其正确定位在患者的天然主动脉瓣环内,支架或框架就可以扩展并将其固定到位。无缝线主动脉瓣的主要优点是它们可以简化手术程序,减少手术时间并可能改善结果,特别是对于风险较高或因其他医疗状况而手术途径有限的患者。与任何医疗手术一样,主动脉瓣置换装置(包括无缝线瓣膜)的选择取决于患者的具体情况、整体健康状况和个人风险因素。

基于手术的见解

根据手术,主动脉瓣置换装置市场分为开放手术和微创手术。微创手术领域在2022年占据了更大的市场份额,预计2022-2030年期间复合年增长率将更高。与传统的开放手术相比,微创主动脉瓣置换手术是一种侵入性较小的方法。它涉及制作较小的切口,通常使用专门的手术器械和视频辅助技术,进入心脏,用人工瓣膜(机械瓣膜或生物瓣膜)替换工作不良的主动脉瓣。微创技术的潜在好处包括缩短住院时间、减少疤痕和加快恢复时间(在正常情况下)。大多数情况下都会选择 TAVR 手术,因为它们造成的组织损伤较小,并且恢复时间也较快。据《新英格兰医学杂志》报道,自 2007 年这项技术问世以来,TAVR 手术的数量显着增加,因为手术替代已被证明不适合老年患者。随着医疗技术的进步,这些微创方法为需要主动脉瓣置换术的患者提供了更多选择并改善了结果。

基于最终用户的见解

就最终用户而言,主动脉瓣置换设备市场分为医院和诊所、门诊手术中心等。到2022年,医院和诊所占据最大的市场份额。医院和诊所是主动脉瓣置换装置的最大最终用户,这些装置可用于治疗不同年龄组患有各种疾病的患者。许多患者前往医院寻求急性和慢性疾病的治疗。医院的医务人员为患者提供便捷的服务和最好的护理。因此,医院的目标是恢复和维持公众的健康。医院工作人员了解不同的主动脉瓣置换装置。慢性病患病率的上升、老年人口的增加以及医院数量的增加主要促进了医院领域主动脉瓣置换市场的增长。老年人住院的可能性是中年成年人的两倍;大约 17% 的 65 岁及以上的美国人每年至少住院一次,而只有 8% 的 45-64 岁成年人需要住院治疗。心血管疾病、癌症、中风和神经系统疾病是老年患者住院的主要原因。因此,在预测期内,住院患者数量的增加可能会推动医院市场的增长。

健康平台市场(按产品) - 2022 年和 2030 年

区域分析

北美在2022年主动脉瓣置换装置市场中占据主导地位,占据最大份额,其中美国、加拿大和墨西哥是该区域市场的主要贡献者生长。美国是该地区主动脉瓣置换装置的最大市场。北美主动脉瓣置换装置市场的增长归因于心脏病患病率的上升以及监管批准、研发活动和新产品发布数量的增加。此外,该产品的技术进步可能会为该地区的主动脉瓣置换装置市场提供增长机会。

据克利夫兰诊所称,心脏瓣膜疾病影响着该地区约 2.5% 的人。我们。这些包括瓣膜反流(泄漏)或狭窄(变窄)。二尖瓣关闭不全和主动脉瓣狭窄是美国最常见的瓣膜疾病。美国有超过 200 万人患有心脏瓣膜渗漏。美国处于北美主动脉瓣置换设备市场的前沿。在美国有近 150 万人患有主动脉瓣狭窄。根据美国国立卫生研究院(NIH)公布的数据,2021年,该国每年进行约78,000例经导管主动脉瓣植入(TAVI)手术。该地区主要参与者的存在和临床研究数量的增加推动了市场的增长。私营机构采取的举措预计也将促进市场的增长。例如,爱德华兹生命科学基金会正在赞助美国心脏协会的瓣膜疾病教育中心和美国大使计划。因此,上述因素预计将推动美国市场的增长。

该报告介绍了全球主动脉瓣置换设备市场的领先参与者。其中包括 Virgin Pulse Inc、Limeade Inc、Optum Inc、Vitality Group International Inc、Bravo Wellness LLC、Sonic Boom Wellness LLC、WebMD Health Services Group Inc、Fitbit LLC、Asset Health Inc、Healthcheck360、Marquee Health LLC、Wellright Inc、Wellworks for您,Wellable LLC、Wellness 360 Technologies Inc、WellSteps.com LLC 和 CHC Wellbeing Inc.

2023 年 2 月,美敦力重新推出了 Harmony 经导管肺动脉瓣 (TPV) 系统,这是一种微创替代开放式肺动脉瓣的系统。 -对具有天然或手术修复右心室流出道(RVOT)的先天性心脏病患者进行心脏手术。2023年1月,雅培公司最新一代经导管主动脉瓣植入(TAVI)系统获得美国食品和药物管理局(FDA)批准,Navitor,用于治疗处于心脏直视手术高风险或极端风险的严重主动脉瓣狭窄患者。 Navitor TAVI 系统是该公司全面的经导管结构性心脏产品组合的最新成员,为医生和患者提供一些最常见和最严重的心脏病的微创治疗选择。2021 年 7 月,Limeade 收购了员工倾听领域的先驱 TINYPULSE软件。此次收购将联合两家致力于帮助客户创造健康员工体验的公司。2021 年 11 月,Virgin Pulse 收购了 Welltok,以推动更好的健康成果和降低成本。此次收购将使两家公司能够推出业界首个端到端参与和激活平台,为整个健康界的客户、会员和消费者提供支持。公司简介

Abbott LaboratoriesMedtronic PlcBoston Scientific CorpLivaNova PlcEdwards Lifesciences CorpBraile Biomedica Industry, Commerce and Representations LtdArtivion IncJenaValve Technology IncVenus MedTech HangZhou IncLabcor Laboratorios Ltda
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the driving factors for the aortic valve replacement devices market?

The factors driving the growth of the aortic valve replacement devices market include the rising number of aortic valve replacement surgeries and increasing demand for minimally invasive techniques. However, the product recalls of aortic valve replacement devices hampers the growth of the aortic valve replacement devices market.

Who are the major players in the aortic valve replacement devices market?

The aortic valve replacement devices market majorly consists of the following players, Abbott Laboratories, Medtronic Plc, Boston Scientific Corp, LivaNova Plc, Edwards Lifesciences Corp, Braile Biomedica Industry, Commerce and Representations Ltd, Artivion Inc, JenaValve Technology Inc, Venus MedTech HangZhou Inc, and Labcor Laboratorios Ltda.

Which segment is dominating the aortic valve replacement devices market?

Based on product, the aortic valve replacement devices market is bifurcated into mechanical valve and sutureless valve. The sutureless valve segment held the larger market share in 2022 and the same segment registered a significant CAGR in the aortic valve replacement devices market in 2022-2030.

What was the estimated aortic valve replacement devices market size in 2022?

The aortic valve replacement devices market was valued at US$ 7,113.39 billion in 2022.

What are the growth estimates for the aortic valve replacement devices market till 2030?

The aortic valve replacement devices market is expected to be valued at US$ 18,070.32 billion in 2030.

What is aortic valve replacement devices?

Aortic valve repair and aortic valve replacement are methods that treat diseases affecting the aortic valve. The aortic valve is one of four valves that regulate blood flow through the heart. The aortic valve separates the heart's main pumping chamber and the main artery that supplies oxygen-rich blood to body. Aortic valve repair or aortic valve replacement treats aortic valve disease and help restore normal blood flow, reduces symptom, prolong life and help preserves the function of the heart muscle.

The List of Companies - Aortic Valve Replacement Devices Market

  1. Abbott Laboratories
  2. Medtronic Plc
  3. Boston Scientific Corp
  4. LivaNova Plc
  5. Edwards Lifesciences Corp
  6. Braile Biomedica Industry, Commerce and Representations Ltd
  7. Artivion Inc
  8. JenaValve Technology Inc.
  9. Venus MedTech HangZhou Inc.
  10. Labcor Laboratorios Ltda

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports